Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
NioCorp Developments (NB) prices $20 million public offering at $2.60 per share
-
NioCorp Announces Pricing of $20.0 Million Underwritten Public Offering of Common Shares
-
Amplitech Group's (AMPG) 5G Division Secures Company-Record Approx. US$11 Million Purchase Orders
-
AmpliTech Group’s 5G Division Secures Company-Record Approx. US$11 Million Purchase Orders As Part Of A New Multi-Year LOI From Tier 1 North American MNO
-
Japan Go IPO Summit Announces Roster of Expert Speakers for Event June 5th in Tokyo
-
/C O R R E C T I O N -- Marcum Asia CPAs LLP/
-
B2i Digital Supports Maxim Group's Critical Minerals Summit as a Marketing Partner
-
Signing Day Sports Signs Non-Binding Letter of Intent to Acquire All Equity of blockchAIn Digital Infrastructure, a Profitable Data Hosting Company
-
Lucid Diagnostics (LUCD) Announces Closing of Public Offering of Common Stock
-
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
-
Spartan Capital Securities Announces the Hiring of Robert Forte
-
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
-
Lucid Diagnostics (LUCD) Announces Proposed Public Offering of Common Stock
-
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
-
Alliance Advisors to Sponsor the Jones Las Vegas Healthcare and Technology Innovation Conference on April 8-9, 2025
-
AGP Prime Adds David Miller as Senior Managing Director
-
Faraday Future to Participate in Jones Technology and Innovation Conference in Las Vegas April 8-9, 2025
-
Ellenoff Grossman & Schole LLP to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
-
B2i Digital Named Marketing Partner for Centri Capital Conference
-
UY SCUTI ACQUISITION CORP. ANNOUNCES CLOSING OF $50 MILLION INITIAL PUBLIC OFFERING
-
UY SCUTI ACQUISITION CORP. ANNOUNCES PRICING OF $50 MILLION INITIAL PUBLIC OFFERING
-
TAG1 Inc. to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
-
HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results
-
BioMedNewsBreaks — Kairos Pharma Ltd. (NYSE American: KAPA) Gains Traction with Conference Participation and Analyst Coverage
-
Kairos Pharma Ltd. Highlights Participation in Recent and Upcoming Scientific and Industry Events
-
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
-
Cloudastructure (CSAI) Secures $4.5M Preferred Investment from Existing Institutional Investor to Accelerate Growth
-
Cloudastructure Secures $4.5 Million Preferred Investment from Existing Institutional Investor to Accelerate Growth
-
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025
-
OceanPal (OP) and B2i Digital partner to expand investor engagement
-
OceanPal Inc. Partners With B2i Digital as a Featured Company to Expand Investor Awareness
-
Wang & Lee Group (WLGS) Prices 3.53M Share Offering at $3.40/sh
-
Wang & Lee Group Announces Pricing of $12.0 Million Registered Direct Offering
-
Wang & Lee Group Announces Pricing of $12.0 Million Registered Direct Offering
-
Strategy (MSTR) acquired approximately 6,911 more bitcoins
-
Damon Inc. Announces Closing of Upsized $16.5 Million Underwritten Public Offering
-
Damon Inc. Announces Pricing of Upsized $16.5 Million Underwritten Public Offering
-
Castellum Announces Closing of $4.5 Million Public Offering of Common Stock and Warrants
-
B2i Digital Named Marketing Partner for Ladenburg Thalmann Technology Innovation EXPO25
-
PESG Report: Silexion Therapeutics’ Breakthrough Data Shows SIL204's impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment
-
Castellum Announces Pricing of $4.5 Million Public Offering of Common Stock and Warrants
-
Castellum Announces Proposed Public Offering of Common Stock and Warrants
-
Dogwood Therapeutics (DWTX) Prices 579K Share Offering at $8.26/sh
-
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
-
AGM Group Holdings Inc. Announces Closing of $5.4 Million Offering
-
PESG Industry Update: Anticipation Rises as Silexion Therapeutics Approaches a Key Preclinical Data That Could Be Transformational
-
AGM Group Holdings Inc. Announces Pricing of $5.4 Million Public Offering
-
MacKenzie Realty Capital (MKZR) Announces 2.83M Share Offering at $1.71/sh
-
MacKenzie Realty Capital Announces Pricing of $4.8 Million Registered Direct Offering and Concurrent Private Placement

